General Information
Version
5.0
Revision date
2025-02-20
Product name
MEGM SingleQuots
Product name
MEGM SingleQuots
Identification on the label/Trade name
Clonetics
1.2.1 Relevant identified uses
For research use only
1.2.2. Uses advised against
NOT FOR USE IN GMP MANUFACTURING, NOR HUMAN on use OR ANIMAL IN VIVO OR DIAGNOSTIC USE
Emergency telephone
+41 61 313 94 94
Icons in SDS
Company Information
company name
Lonza Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sds@lonza.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
P261 Avoid breathing mist or vapours. P280 Wear protective gloves. P284 Wear respiratory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Hazardous Ingredients
Gentamicin, sulfate (salt)
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
(REGULATION (EC) No 1272/2008) Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction.
